InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the detailed record of transactions filed by Gelder Mark S. MD, Directeur Médical. Director active across 1 company, notably Onconova Therapeutics, Inc.. Cumulatively, 3 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 28 September 2021. The latest transaction was filed on 28 September 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Gelder Mark S. MD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
5,833 sharesCommon StockSEC:0001415889-23-002168:0
4,650 sharesCommon StockSEC:0001415889-22-008260:0
2,381 shares@ US$4.20100.0% of flowCommon StockSEC:0001179110-21-008981:0
Canonical exit: 27 Dec 2021 (T+90)
3 of 3 declarations
About Gelder Mark S. MD
Mark S. Gelder is the Chief Medical Officer at Onconova Therapeutics, Inc. He is responsible for the company's medical and clinical strategies, ensuring innovation in treatment development. His medical expertise is essential for Onconova's mission.
